Histological differentiation grade and microvascular invasion of hepatocellular carcinoma predicted by dynamic contrast-enhanced MRI

Journal of Magnetic Resonance Imaging

Volumn 36, Issue 3, 2012, Pages 641-647

  Witjes, Caroline D M ^a   Willemssen, François E J A ^a   Verheij, Joanne ^a   Van Der Veer, Sacha J ^a   Hansen, Bettina E ^a   Verhoef, Cornelis ^a   De Man, Robert A ^a   Ijzermans, Jan N M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

differentiation grade; dynamic contrast enhanced MRI; hepatocellular carcinoma; microvascular invasion; survival; time intensity curve

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROVASCULARIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHILD; CHILD, PRESCHOOL; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; INFANT; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84865313636     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23681     Document Type: Article

References (23)

1. Llovet JM, Burroughs A, Bruix J,. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917. (Pubitemid 37518510)
2. Bruix J, Sherman M,; Practice Guidelines Committee, American Association for Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-1236. (Pubitemid 43112690)
3. Colli A, Fraquelli M, Casazza G, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006; 101: 513-523. (Pubitemid 43340927)
4. van den Bos IC, Hussain SM, Dwarkasing RS, et al. MR imaging of hepatocellular carcinoma: relationship between lesion size and imaging findings, including signal intensity and dynamic enhancement patterns. J Magn Reson Imaging 2007; 26: 1548-1555. (Pubitemid 350291283)
5. Wang L, van den Bos IC, Hussain M, Pattynama PM, Vogel MW, Krestin GP,. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis. Acta Radiol 2008; 49: 6-18.
6. Zou WL, Zang YJ, Chen XG, Shen ZY,. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation. Hepatobil Pancreat Dis Int 2008; 7: 145-151.
7. Sakata J, Shirai Y, Wakai T, Kaneko K, Nagahashi M, Hatakeyama K,. Preoperative predictors of vascular invasion in hepatocellular carcinoma. Eur J Surg Oncol 2008; 34: 900-905.
8. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 2008; 15: 1375-1382.
9. Nathan H, Schulick RD, Choti MA, Pawlik TM,. Predictors of survival after resection of early hepatocellular carcinoma. Ann Surg 2009; 249: 799-805.
10. Zhang XF, Meng B, Qi X, et al. Prognostic factors after liver resection for hepatocellular carcinoma with hepatitis B virus-related cirrhosis: surgeon's role in survival. Eur J Surg Oncol 2009; 35: 622-628.
11. Lauwers GY, Terris B, Balis UJ, et al. Prognostic histologic indicators of curatively resected hepatocellular carcinomas: a multi-institutional analysis of 425 patients with definition of a histologic prognostic index. Am J Surg Pathol 2002; 26: 25-34. (Pubitemid 34019989)
12. Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009; 137: 850-855.
13. Okusaka T, Okada S, Ueno H, et al. Satellite lesions in patients with small hepatocellular carcinoma with reference to clinicopathologic features. Cancer 2002; 95: 1931-1937. (Pubitemid 35222173)
14. Eguchi S, Takatsuki M, Hidaka M, et al. Predictor for histological microvascular invasion of hepatocellular carcinoma: a lesson from 229 consecutive cases of curative liver resection. World J Surg 2010; 34: 1034-1038.
15. Pinheiro JC, Bates DM,. Mixed-effects models in S and S-Plus. New York: Springer; 2002. p 377-379.
16. Okamoto D, Yoshimitsu K, Nishie A, et al. Enhancement pattern analysis of hypervascular hepatocellular carcinoma on dynamic MR imaging with histopathological correlation: validity of portal phase imaging for predicting tumor grade. Eur J Radiol 2011 [Epub ahead of print].
17. Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B,. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI? AJR Am J Roentgenol 2011; 196: 1083-1089.
18. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211: 101-110. (Pubitemid 29161739)
19. Hayes C, Padhani AR, Leach MO,. Assessing changes in tumor vascular function using dynamic contrast-enhanced magnetic resonance imaging. NMR Biomed 2002; 15: 154-163. (Pubitemid 34213405)
20. Padhani AR,. Dynamic contrast-enhanced MRI in clinical oncology current status and future directions. J Magn Reson Imaging 2002; 16: 407-422. (Pubitemid 35167876)
21. Lavini C, Pikaart BP, de Jonge MC, Schaap GR, Maas M,. Region of interest and pixel-by-pixel analysis of dynamic contrast enhanced magnetic resonance imaging parameters and time-intensity curve shapes: a comparison in chondroid tumors. Magn Reson Imaging 2009; 27: 62-68.
22. Kitao A, Matsui O, Yoneda N, et al. The uptake transporter OATP8 expression decreases during multistep hepatocarcinogenesis: correlation with gadoxetic acid enhanced MR imaging. Eur Radiol 2011; 21: 2056-2066.
23. Di Tommaso L, Destro A, Seok JY, et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol 2009; 50: 746-754.